Felice H Tsang
Overview
Explore the profile of Felice H Tsang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsang F, Stolper R, Hanifi M, Cornell L, Francis H, Davies B, et al.
Nucleic Acids Res
. 2024 Aug;
52(17):10180-10193.
PMID: 39106157
While the elements encoding enhancers and promoters have been relatively well studied, the full spectrum of insulator elements which bind the CCCTC binding factor (CTCF), is relatively poorly characterized. This...
2.
Au V, Tsang F, Man K, Fan S, Poon R, Lee N
Biosci Trends
. 2014 May;
8(2):101-10.
PMID: 24815387
Ankyrin repeat and SOCS box containing 4 (ASB4) involves in physiological process of ubiquitin-mediated proteasomal degradation. Our previous study demonstrated high expression of ASB4 in hepatocellular carcinoma (HCC) cell lines....
3.
Tsang F, Au V, Lu W, Shek F, Liu A, Luk J, et al.
Dig Dis Sci
. 2014 May;
59(10):2477-87.
PMID: 24811246
Background: MicroRNAs (miRNAs) belong to a group of small non-coding RNA with differential expression in tumors, including hepatocellular carcinoma (HCC). Aim: This study investigates the involvement of miR-125b in HCC....
4.
Lee N, Tsang F, Shek F, Mao M, Dai H, Zhang C, et al.
Int J Cancer
. 2009 Dec;
127(4):968-76.
PMID: 19998337
Using comparative proteomic and genomic approaches, the authors identified eukaryotic translation initiation factor 5A (eIF5A) as an oncofetal molecule highly abundant in mouse embryonic livers and human hepatocellular carcinoma (HCC)...
5.
Tsang F, Lee N, Luk J
Protein Pept Lett
. 2009 May;
16(5):530-8.
PMID: 19442232
Hepatocellular carcinoma (HCC) is a malignant tumor unresponsive to most current therapies. Small peptides, either synthetic or derived from natural proteins, are found promising in treating HCC. Herein, different types...
6.
Lee N, Chen L, Lin M, Tsang F, Yeung C, Poon R, et al.
J Proteome Res
. 2009 Jan;
8(3):1293-303.
PMID: 19161326
Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated biomarkers that can predict natural history of malignant progression are lacking. The present study explored the proteome-wide patterns of...